Hangzhou AGS MedTech Co Ltd
SSE:688581
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
45.1525
87.0506
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hangzhou AGS MedTech Co Ltd
Change in Working Capital
Hangzhou AGS MedTech Co Ltd
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
H
|
Hangzhou AGS MedTech Co Ltd
SSE:688581
|
Change in Working Capital
-ÂĄ111.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Change in Working Capital
-ÂĄ623.6m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Change in Working Capital
-ÂĄ2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-18%
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Change in Working Capital
-ÂĄ9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
||
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Change in Working Capital
-ÂĄ901.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Change in Working Capital
-ÂĄ3.2B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hangzhou AGS MedTech Co Ltd
Glance View
Hangzhou AGS MedTech Co., Ltd. engages in the research and development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 501 full-time employees. The company went IPO on 2023-05-19. The firm's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.
See Also
What is Hangzhou AGS MedTech Co Ltd's Change in Working Capital?
Change in Working Capital
-111.9m
CNY
Based on the financial report for Dec 31, 2023, Hangzhou AGS MedTech Co Ltd's Change in Working Capital amounts to -111.9m CNY.
What is Hangzhou AGS MedTech Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
-28%
Over the last year, the Change in Working Capital growth was -20%. The average annual Change in Working Capital growth rates for Hangzhou AGS MedTech Co Ltd have been -28% over the past three years .